Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 89

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 89
---
centive Plan | ​ |   |            |   |

| ​ |     | ​ | ​ | The board unanimously recommends votingFORthe approval of the Amended and Restated 2011 Stock Incentive Plan. | ​ |

Our 2011 Stock Incentive Plan (the “2011 Plan”) was originally adopted by our board of directors and approved by our stockholders in December 2010. An amendment and restatement of the 2011 Plan was approved by our stockholders at our annual meeting of stockholders in 2012, 2014, 2016, 2019, 2021 and again in 2023. On March 12, 2025, our board, upon recommendation of the People & Compensation Committee, adopted, subject to stockholder approval, an amendment and restatement of the 2011 Plan, which we refer to as the A&R 2011 Plan, to increase the number of shares of common stock authorized for grant by 2,500,000 newly reserved shares, resulting in an aggregate share authorization of up to 22,254,537 shares, of which the 2,500,000 newly reserved shares plus the remaining share pool of 390,405 (as of April 1, 2025) would be available for grant, as described below. Key Features of the A&R 2011 Plan The A&R 2011 Plan includes several features that are consistent with the interests of our stockholders and sound corporate governance practices, including the following: • No automatic share replenishment or “evergreen” provision. There is no evergreen feature pursuant to which the shares authorized for issuance under the A&R 2011 Plan can be automatically replenished. • No discounted options or SARs. Stock options and stock appreciation rights, or SARs, may not be granted with an exercise or measurement price lower than the fair market value of the underlying shares on the date of grant (except that if the award is granted with an exercise price or measurement price to be determined on a future date, the price may not be less than the fair market value on such future date). • No repricing of options or SARs without stockholder approval. The A&R 2011 Plan prohibits the repricing of stock options or SARs without prior stockholder approval. • No liberal share counting or “recycling” of shares. Shares delivered to our Company to purchase shares upon exercise of an award or to satisfy tax withholding obligations will not become available for issuance under